Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: SERV stock price vs OPK: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at OPK's multiple
Needs OPK P/S.
Implied fair value · at SERV's multiple
Needs SERV P/S.
Metric by metric
Live quote
Price unavailable
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: SERV FY 2025 (ended Dec 31, 2025) · OPK FY 2025 (ended Dec 31, 2025).
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
SERVE ROBOTICS INC. · implied price per share
Bear
$0.97
Base
$1.14
Bull
$1.31
OPKO Health, Inc. · implied price per share
Bear
-$1.74
Base
-$2.04
Bull
-$2.35
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.00x
0.54x
Net debt / EBITDA
Leverage against operating earnings
1.10x
-3.43x
Cash and equivalents
Liquid reserves on the balance sheet
$106.24M
$368.94M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
TERADYNE, INC
SERV vs TER
IROBOT CORP
SERV vs IRBT
DEXCOM INC
SERV vs DXCM
COGNEX CORP
SERV vs CGNX
ROCKWELL AUTOMATION, INC
SERV vs ROK
UiPath, Inc.
SERV vs PATH
AMARIN CORP PLC\UK
SERV vs AMRN
Sarepta Therapeutics, Inc.
SERV vs SRPT
Amphastar Pharmaceuticals, Inc.
SERV vs AMPH
SUPERNUS PHARMACEUTICALS, INC.
SERV vs SUPN
Harmony Biosciences Holdings, Inc.
SERV vs HRMY
$1.00M
$687.93M
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
Based on an earlier data snapshot. Review the filing dates below or refresh after signing in.
If you believe SERV can sustain very high revenue growth while rapidly normalizing gross and operating margins, then holding the stock can be justified because the current P/S and EV/Revenue multiples are still being paid for that future scaling optionality.
On a revenue multiple basis, SERV screens dramatically richer than OPK, with P/S at 184.2x versus 1.9x and EV/Revenue at 144.5x versus 2.4x. The implied price of $0.07 versus the current $6.31 suggests a -99.0% downside under OPK P/S framework, but OPK-implied range of $0.06 to $6.64 and SERV’s historical band of $5.68 to $6.94 show the stock is still trading within its own recent range.
Supporting Metrics
